JP2021519330A - ムメフラールを含む認知障害関連疾患の予防又は治療用組成物 - Google Patents

ムメフラールを含む認知障害関連疾患の予防又は治療用組成物 Download PDF

Info

Publication number
JP2021519330A
JP2021519330A JP2020552400A JP2020552400A JP2021519330A JP 2021519330 A JP2021519330 A JP 2021519330A JP 2020552400 A JP2020552400 A JP 2020552400A JP 2020552400 A JP2020552400 A JP 2020552400A JP 2021519330 A JP2021519330 A JP 2021519330A
Authority
JP
Japan
Prior art keywords
mumefural
dementia
cognitive
memory
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020552400A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021519330A5 (enExample
Inventor
キョン ジヨン，ウォン
キョン ジヨン，ウォン
バン，ジヒェ
ソ キム，ミン
ソ キム，ミン
Original Assignee
コリア インスティテュート オブ オリエンタル メディシン
コリア インスティテュート オブ オリエンタル メディシン
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by コリア インスティテュート オブ オリエンタル メディシン, コリア インスティテュート オブ オリエンタル メディシン filed Critical コリア インスティテュート オブ オリエンタル メディシン
Publication of JP2021519330A publication Critical patent/JP2021519330A/ja
Publication of JP2021519330A5 publication Critical patent/JP2021519330A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/20—Inorganic substances, e.g. oligoelements
    • A23K20/24—Compounds of alkaline earth metals, e.g. magnesium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A23K20/121—Heterocyclic compounds containing oxygen or sulfur as hetero atom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/174—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/322—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Physiology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Fodder In General (AREA)
JP2020552400A 2018-03-27 2019-03-05 ムメフラールを含む認知障害関連疾患の予防又は治療用組成物 Pending JP2021519330A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR10-2018-0035324 2018-03-27
KR1020180035324A KR102037944B1 (ko) 2018-03-27 2018-03-27 무메푸랄을 포함하는 인지장애 관련 질환의 예방 또는 치료용 조성물
PCT/KR2019/002545 WO2019190069A1 (ko) 2018-03-27 2019-03-05 무메푸랄을 포함하는 인지장애 관련 질환의 예방 또는 치료용 조성물

Publications (2)

Publication Number Publication Date
JP2021519330A true JP2021519330A (ja) 2021-08-10
JP2021519330A5 JP2021519330A5 (enExample) 2021-09-16

Family

ID=68062313

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020552400A Pending JP2021519330A (ja) 2018-03-27 2019-03-05 ムメフラールを含む認知障害関連疾患の予防又は治療用組成物

Country Status (6)

Country Link
US (1) US20210106550A1 (enExample)
EP (1) EP3789023A4 (enExample)
JP (1) JP2021519330A (enExample)
KR (1) KR102037944B1 (enExample)
AU (1) AU2019241803A1 (enExample)
WO (1) WO2019190069A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102301757B1 (ko) 2020-12-18 2021-09-13 서울대학교산학협력단 스트레스로 인한 기억력 감퇴 억제 및 학습 능력 향상을 위한 천연 혼합 조성물
CN115531368A (zh) * 2021-06-14 2022-12-30 谭文 R-氨基甲酸酯-β-苯乙醇胺类化合物治疗学习和记忆缺陷以及神经退行性疾病的应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013540131A (ja) * 2010-10-04 2013-10-31 コリア インスティチュート オブ オリエンタル メディシン 烏梅抽出物を含有する痴呆（認知症）予防または治療用組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100525474B1 (ko) * 2003-10-07 2005-11-02 롯데제과주식회사 항스트레스 및 뇌기능 개선 효과를 가지는 가미사군자탕 함유 의약품
JP2005289940A (ja) * 2004-04-05 2005-10-20 Hiroko Ito フリーラジカル消去剤
RU2327480C1 (ru) * 2007-05-23 2008-06-27 Виктор Иванович Рощин Активный ингредиент лекарственного средства, лекарственное средство, фармацевтическая композиция и способ лечения больных с дементным синдромом
KR101144197B1 (ko) * 2009-03-31 2012-05-11 전남대학교산학협력단 신생혈관형성 억제제 및 이를 이용한 천연산물 항비만제
KR20140144785A (ko) 2013-06-11 2014-12-22 한국식품연구원 유자(Citrus junos Tanaka) 추출물을 유효성분으로 포함하는 기억력 및 학습 능력 증진용 조성물
KR101823892B1 (ko) 2014-03-10 2018-02-01 우석대학교 산학협력단 기억력 개선, 인지능력 개선, 치매 예방, 지연 또는 치료 효과를 나타내는 봉선화 추출물, 이를 유효성분으로 하는 약제학적 조성물, 이를 유효성분으로 포함하는 기능성 건강보조식품 및 봉선화 추출물의 제조방법
KR101837444B1 (ko) 2016-10-25 2018-03-13 한국 한의학 연구원 양지꽃 추출물을 유효성분으로 함유하는 인지기능 장애의 예방, 개선 또는 치료용 조성물

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013540131A (ja) * 2010-10-04 2013-10-31 コリア インスティチュート オブ オリエンタル メディシン 烏梅抽出物を含有する痴呆（認知症）予防または治療用組成物

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
MOLECULAR SIMULATION, vol. 37, no. 11, JPN6021043629, 2011, pages 923 - 931, ISSN: 0004632975 *
日本食品科学工学会誌, vol. 50, no. 4, JPN6021043631, 2003, pages 188 - 192, ISSN: 0004799011 *

Also Published As

Publication number Publication date
EP3789023A4 (en) 2022-03-30
EP3789023A1 (en) 2021-03-10
KR102037944B1 (ko) 2019-10-29
WO2019190069A1 (ko) 2019-10-03
AU2019241803A1 (en) 2020-11-19
US20210106550A1 (en) 2021-04-15
KR20190113105A (ko) 2019-10-08

Similar Documents

Publication Publication Date Title
EP3483256A1 (en) Akkermansia muciniphila strain having effect of preventing or treating degenerative brain diseases or metabolic diseases, and use thereof
JP6774664B2 (ja) 退行性脳疾患の予防又は治療効果を有するアガトバキュラム属菌株及びその用途
EA025256B1 (ru) Композиция, подходящая для лечения нарушений липидного обмена
US20240358729A1 (en) Composition containing 2'-fl for ameliorating, preventing or treating diseases caused by reduction of dopamine
KR20240057401A (ko) 파라잔틴-기반 카페인 대용 조성물 및 느린 카페인 대사자에서의 이의 사용 방법
AU2017336291A1 (en) Omega 3 fatty acids, no releasing compound and vitamin B12 as neuroprotectant in patients with no dementia
JP2018537091A (ja) 中鎖トリグリセリド組成物
WO2018220886A1 (ja) リポ多糖を用いた脳機能改善剤、食品及び医薬品
AU2024274445A1 (en) Sleep-improving compositions and methods of use
JP2021519330A (ja) ムメフラールを含む認知障害関連疾患の予防又は治療用組成物
CN106389740A (zh) 一种预防和/或延缓老年轻度认知障碍的组合物及其使用方法
He et al. Luteolin attenuates cognitive dysfunction induced by chronic cerebral hypoperfusion through the modulation of the PI3K/Akt pathway in rats
JP7372269B2 (ja) α－ラクトアルブミンに基づく医薬品または食品サプリメントの調製物
US11607433B2 (en) Composition for preventing, improving, or treating autism spectrum disorders including Agathobaculum sp. strain as active ingredient
AU2024204290A1 (en) Compositions and methods for treating depression
CN110475553A (zh) 减轻未患痴呆的个体的认知衰老的组合物和方法
EP1977748B1 (en) Compounds having neuroprotective properties
Nie et al. Vitamin D3 treatment reduced epileptic neuronal damage by inhibiting apoptosis and increasing vitamin D receptor expression in an in vivo epileptic model
JP7762980B2 (ja) エルゴチオネイン、またはセレノネインを用いる自閉症スペクトラム障害の治療方法
EP3388061A1 (en) Omega 3 fatty acids, no releasing compound, vitamin b12 and choline as neuroprotectant in patients with no dementia
EP4353261A1 (en) Nutraceutic combination and its use in the treatment of neurological disorders
Cederwall An evaluation of non-pharmacological, non-invasive complementary interventions for reducing Parkinson's disease symptom severity and rate of disease progression
CN119817809A (zh) 一种有利于改善大脑认知、记忆、睡眠以及用于预防和改善阿尔茨海默症的组合物
CN114984034A (zh) 一种寡糖类化合物的应用
HK40015331B (en) Brain function-improving agent, food, and medicine using lipopolysaccharide

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20201127

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20201127

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20211102

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20220614